Publications by authors named "Karin Bilger"

Claim this Profile
T
Total Body Irradiation-Based Versus Chemotherapy-Alone Myleloblative Conditioning Regimen Before Hematopoietic Allogeneic Stem Cell Transplantation in Adults With Acute Lymphoblastic Leukemia: A Multi-Institutional Study From the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Yazid Belkacemi, Kamel Debbi, Nhu Hanh To, Regis Peffault de La Tour, Laurent Quero, Karin Bilger

Int J Radiat Oncol Biol Phys· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Hematopoietic Stem Cell Transplantation for Elderly Acute Lymphoblastic Leukemia Patients: A Registry Study From the Société Francophone de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC).
Yves Chalandon, Raynier Devillier, Ariane Boumendil, Stephanie Nguyen, Claude-Eric Bulabois, Karin Bilger

Am J Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.
Patrice Chevallier, Thibaut Leguay, Marc Delord, Cyril Salek, Rathana Kim, Karin Bilger

J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma).
Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, Kamal Bouabdallah, Mathieu Leclerc, Karin Bilger

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
Esther Hazane Leroyer, Nadine Petitpain, Stéphane Morisset, Bénédicte Neven, Martin Castelle, Karin Bilger

Hemasphere· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.
Corentin Orvain, Sylvain Chantepie, Xavier Thomas, Martine Escofrre-Barbe, Francoise Huguet, Karin Bilger

Haematologica· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC.
Gaëlle Rey, Elisabeth Daguenet, Paul Bonjean, Raynier Devillier, Nathalie Fegueux, Karin Bilger

Bone Marrow Transplant· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial.
Florent Malard, Michael Loschi, Anne Huynh, Thomas Cluzeau, Sarah Guenounou, Karin Bilger

EClinicalMedicine· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS.
Claire Michel, Marie Robin, Stephane Morisset, Didier Blaise, Johan Maertens, Karin Bilger

Bone Marrow Transplant· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC.
Paul Chauvet, Annalisa Paviglianiti, Myriam Labopin, Hélène Labussière, Nicolas Boissel, Karin Bilger

Bone Marrow Transplant· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical Trial.
Anne-Charlotte Teyssier, Gérard Michel, Charlotte Jubert, Fanny Rialland, Sandrine Visentin, Karin Bilger

Transplant Cell Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Norbert Schmitz, Lorenz Truemper, Krimo Bouabdallah, Marita Ziepert, Mathieu Leclerc, Karin Bilger

Blood· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study.
Alienor Xhaard, Constance Xhaard, Maud D'Aveni, Helene Salvator, Marie-Laure Chabi, Karin Bilger

Br J Haematol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC.
Amandine Le Bourgeois, Myriam Labopin, Ambroise Marçais, Regis Peffault de Latour, Didier Blaise, Karin Bilger

Ann Hematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib.
Dominique Levêque, Guillaume Becker, Karin Bilger, Shanti Natarajan-Amé

Clin Pharmacokinet· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia.
Mathieu Baldacini, Raoul Pop, Laurent Sattler, Laurent Mauvieux, Karin Bilger

Br J Haematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia.
Jonathan Bond, Aurore Touzart, Stéphane Leprêtre, Carlos Graux, Mario Bargetzi, Karin Bilger

Haematologica· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD.
Gérard Socié, Noel Milpied, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Fürst, Karin Bilger

Blood Adv· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clofarabine/busulfan-based reduced intensity conditioning regimens provides very good survivals in acute myeloid leukemia patients in complete remission at transplant: a retrospective study on behalf of the SFGM-TC.
Amandine Le Bourgeois, Myriam Labopin, Mathieu Leclerc, Régis Peffault de Latour, Jean-Henri Bourhis, Karin Bilger

Oncotarget· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total body irradiation in allogeneic bone marrow transplantation conditioning regimens: A review.
Adrien Paix, Delphine Antoni, Waisse Waissi, Marie-Pierre Ledoux, Karin Bilger

Crit Rev Oncol Hematol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD.
Gérard Socié, Stéphane Vigouroux, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Fürst, Karin Bilger

Blood· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.
Bernard Rio, Sylvie Chevret, Stéphane Vigouroux, Patrice Chevallier, Sabine Fürst, Karin Bilger

Biol Blood Marrow Transplant· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial.
Patrice Chevallier, Myriam Labopin, Gérard Socié, Reza Tabrizi, Sabine Furst, Karin Bilger

Haematologica· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Moshe Yeshurun, Myriam Labopin, Didier Blaise, Jan J Cornelissen, Henrik Sengeloev, Karin Bilger

Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of disease status and stem cell source on the results of reduced intensity conditioning transplant for Hodgkin's lymphoma: a retrospective study from the French Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Ambroise Marcais, Raphael Porcher, Marie Robin, Mohamad Mohty, Mauricette Michalet, Karin Bilger

Haematologica· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis